Literature DB >> 24597690

Outcomes of revascularization treatment in immature dog's teeth.

Abbas Ali Khademi1, Omid Dianat, Faranak Mahjour, Seyed Mohammad Razavi, Farnaz Younessian.   

Abstract

AIM: The purpose of the current study was to examine the success rate of a revascularization treatment protocol involving canal space disinfection using copious irrigation, a triantibiotic dressing, and induction of a blood clot matrix in immature dog's teeth.
MATERIALS AND METHODS: Thirty-six immature mongrel dog's teeth were divided into two experimental and two control groups. The experimental groups included a necrotic-infected group (n = 20) and a vital group (n = 10). In the group with the necrotic-infected teeth, periapical lesions were induced, and disinfection of the canals was carried out using copious irrigation and a triple antibiotic medication (metronidazole, ciprofloxacin, and tetracycline). Subsequently, the periapical tissues were irritated to initiate bleeding, producing a blood clot. A double seal of the coronal access was then placed. In the vital group, the pulp was aseptically removed before the canal was irrigated and periapical tissues irritated to induce bleeding. The same protocol as that used for the necrotic-infected group was used to seal the coronal access. In the positive control group (n = 3), after pulp removal, sterile sponges soaked in plaque suspension were placed in the pulp chambers of the teeth, after which the chambers were sealed. In the negative control group (n = 3), one untouched 1st premolar tooth in each dog was assigned and left to develop naturally. Radiographic and histological findings were evaluated at 3 and 6 months. Data analysis was performed using Fisher's exact test.
RESULTS: The necrotic-infected group radiographically demonstrated apical healing and apical closure in 70% of the cases and thickening of the walls in 40% after 6 months. The vital group showed apical closure in 77% and thickened walls in 44% of the cases after 3 months. Histological findings confirmed the radiographic findings. No significant difference was observed between the two groups (P > 0.05).
CONCLUSIONS: If necrotic-infected canals are effectively disinfected and treated according to the protocol, the ensuing revascularization response is similar to that of vital immature teeth.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  animal model; dog's tooth; immature teeth; pulp revascularization; root canal; trauma; treatment

Mesh:

Year:  2014        PMID: 24597690     DOI: 10.1111/edt.12100

Source DB:  PubMed          Journal:  Dent Traumatol        ISSN: 1600-4469            Impact factor:   3.333


  5 in total

1.  Immunohistological Evaluation of Revascularized Immature Permanent Necrotic Teeth Treated by Platelet-Rich Plasma: An Animal Investigation.

Authors:  Saeed Moradi; Ali Talati; Maryam Forghani; Amir Hossein Jafarian; Mandana Naseri; Shiva Shojaeian
Journal:  Cell J       Date:  2016-08-24       Impact factor: 2.479

2.  Efficacy of i-PRF in regenerative endodontics therapy for mature permanent teeth with pulp necrosis: study protocol for a multicentre randomised controlled trial.

Authors:  Yuee Liang; Rongyang Ma; Lijuan Chen; Xingzhu Dai; Shiya Zuo; Weiyi Jiang; Naiming Hu; Zilong Deng; Wanghong Zhao
Journal:  Trials       Date:  2021-07-06       Impact factor: 2.279

Review 3.  Biomimetic microenvironments for regenerative endodontics.

Authors:  Sagar N Kaushik; Bogeun Kim; Alexander M Cruz Walma; Sung Chul Choi; Hui Wu; Jeremy J Mao; Ho-Wook Jun; Kyounga Cheon
Journal:  Biomater Res       Date:  2016-06-02

4.  Regenerative Endodontic Therapy in the Management of Immature Necrotic Permanent Dentition: A Systematic Review.

Authors:  Faisal T Alghamdi; Alaa E Alqurashi
Journal:  ScientificWorldJournal       Date:  2020-07-13

Review 5.  Roles of Dental Mesenchymal Stem Cells in the Management of Immature Necrotic Permanent Teeth.

Authors:  Dixin Cui; Sihan Yu; Xin Zhou; Ying Liu; Lu Gan; Yue Pan; Liwei Zheng; Mian Wan
Journal:  Front Cell Dev Biol       Date:  2021-05-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.